-
CTIC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
CTI BioPharma (CTIC)
Company Profile
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm |
Cash burn (monthly) | 2.07 mm | 6.06 mm | 3.08 mm | 4.49 mm | 10.37 mm | 6.86 mm |
Cash used (since last report) | 47.67 mm | 139.49 mm | 70.86 mm | 103.49 mm | 238.70 mm | 157.96 mm |
Cash remaining | -23.46 mm | -115.28 mm | -46.65 mm | -79.28 mm | -214.49 mm | -133.75 mm |
Runway (months of cash) | -11.3 | -19.0 | -15.2 | -17.6 | -20.7 | -19.5 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 51.24 mm |
Total shares | 9.61 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Growth Equity Opportunities V | 9.61 mm | $51.24 mm |